Summit Global Investments’s Teladoc Health TDOC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2021
Q1
Sell
-33,597
Closed -$6.72M 572
2020
Q4
$6.72M Sell
33,597
-3,733
-10% -$759K 0.67% 35
2020
Q3
$8.18M Buy
37,330
+21,792
+140% +$4.61M 0.85% 37
2020
Q2
$2.96M Buy
15,538
+9,338
+151% +$1.64M 0.34% 53
2020
Q1
$961K Buy
+6,200
New +$721K 0.14% 85

Other funds holding TDOC

Summit Global Investments's TDOC Position: Q1 2021 in Review

Summit Global Investments sold out of Teladoc Health (TDOC) in Q1 2021, closing a stake of 33,597 shares — an estimated $6.72M sold.

Summit Global Investments first reported a position in TDOC in Q1 2020 and held it in 4 quarters. The position peaked at $8.18M in Q3 2020. 889 funds tracked by Wall St. Rank hold TDOC as of Q1 2021.

  • Summit Global Investments reported no remaining Teladoc Health position as of Q1 2021 after selling out during the quarter.
  • Summit Global Investments sold 33,597 Teladoc Health shares in Q1 2021, an estimated $6.72M.
  • Summit Global Investments first reported a position in Teladoc Health in Q1 2020 and held it in 4 quarters.
  • Summit Global Investments's Teladoc Health position peaked at $8.18M in Q3 2020.
  • 889 funds tracked by Wall St. Rank held Teladoc Health as of Q1 2021.

Based on Summit Global Investments's 13F filing for Q1 2021, filed 27 Jan 2022.